Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. To facilitate shareholder queries, the Company will conduct an investor conference call as part of the transaction. For full details click here.